Table 3

Postnatal (PNA) and postmenstrual age (PMA) at detection of retinopathy of prematurity (ROP), ROP stage 3 and first treatment, time from detected ROP to treatment and number of examinations in relation to gestational age (GA)

GA (weeks)21/22 †2324252627282930Total
Detection first ROP
 PNA (weeks)*
10.9 (7.9:23.1)10.1 (6.3:22.0)9.6 (6.1:27.0)9.0 (6.1:16.3)8.4 (4.9:17.6)8.1 (4.9:15.3)7.9 (4.1:15.0)7.4 (4.7:11.9)7.0 (4.7:11.4)9.0 (4.1:27)
 PMA (weeks)*33.4 (30.4:46.0)33.7 (29.4:45.1)34.0 (31.0:51.3)34.4 (31.6:41.4)34.9 (31.6:44.0)35.4 (32.3:42.4)36.3 (32.9:43.3)36.7 (33.7:41.4)37.7 (34.9:42.1)34.9 (29.4:51.3)
 N68207314353363226170101531855
Detection ROP3
 PNA (weeks)*
11.9 (9.6:23.1)12.0 (8.4:25.6)11.7 (7.3:23.9)11.7 (7.0:27.7)11.7 (7.0:26.1)12.4 (4.9:22.7)10.8 (6.4:17.9)10.6 (6.6:18.4)8.6 (5.0:10.9)11.9 (4.9:27.7)
 PMA (weeks)*34.6 (32.3:46.0)35.5 (31.7:48.7)36.1 (31.7:48.4)37.0 (32.7:53.0)38.1 (33.7:52.9)39.7 (32.3:49.9)39.0 (34.4:46.3)40.1 (36.0:48.3)39.0 (35.1:41.4)36.7 (31.7:53)
 N5314017614712144281510734
First treatment
 PNA (weeks)*
12.4 (9.7:24.3)12.6 (9.4:28.3)12.3 (8.3:21.4)12.6 (7.4:21.9)12.8 (7.0:25.9)12.8 (8.7:17.7)11.6 (7.6:18.9)11.1 (8.0:17.4)NA (Inf:-Inf)12.4 (7:28.3)
 PMA (weeks)*35.1 (32.1:47.1)35.9 (32.9:51.4)36.6 (32.4:45.7)37.9 (33.1:47.0)39.2 (33.1:52.1)40.2 (35.7:45.3)39.6 (36.1:47.7)40.7 (37.6:46.6)NA (Inf:-Inf)36.9 (32.1:52.1)
 N43109120835814940440
Days from first ROP to treatment*18.0 (3:95)17.0 (2:87)20.0 (1:77)28.0 (2:86)24.5 (3:133)30.0 (15:78)12.0 (2:79)22.0 (5:71)NA (Inf:-Inf)22.0 (1:133)
Number of examinations*14.0 (3:42)14.0 (1:39)12.0 (2:40)10.0 (2:37)7.0 (2:35)5.0 (1:27)4.0 (1:29)4.0 (1:24)3.0 (1:21)4.0 (1:42)
Total number of examinations13333722552764076729567257265690523246 038
  • *Median and ranges are given.

  • †There were two infants born at 21 w, both developed ROP stage 3 and were treated for ROP.